Recombinant Mouse TAGAP Protein，His & GST

TAGAP (T-cell activation RhoGTPase-activating protein) is a crucial regulator of immune responses, particularly in T lymphocyte activation and differentiation. Research into the role of TAGAP has gained momentum due to its involvement in various immunological conditions and autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. TAGAP serves as a GTPase-activating protein (GAP), primarily targeting Rho family GTPases, which modulate cytoskeletal dynamics and cellular signaling pathways critical for T-cell function. The structural and functional characterization of TAGAP as a recombinant protein has become essential for understanding its mechanism of action at the molecular level. By producing recombinant TAGAP, researchers can examine its interactions with specific GTPases and downstream effectors, paving the way for potential therapeutic interventions. Furthermore, the study of TAGAP also has implications for vaccine development and enhancing T-cell responses in cancer immunotherapy. Given its pivotal role in shaping immune responses, TAGAP represents a promising target for modulating T cell activity, and ongoing research aims to elucidate its potential as a biomarker or therapeutic target in various diseases. Recent advancements in recombinant protein technology allow for the high-yield expression and purification of TAGAP, facilitating detailed biochemical studies and functional assays to explore its impact on immune cell regulation and overall immunological health.